Secondary Prevention of CVD in LMIC: Care for the Growing Affected PopulationMoran & NarulaDec 1, 201712(4): 271-272DownloadPDF (English)Dec 1, 201712(4): 271-272
The World Heart Federation Roadmap for Nonvalvular Atrial FibrillationMurphy et al.Dec 1, 201712(4): 273-284DownloadPDF (English)Dec 1, 201712(4): 273-284
Feasibility of Using Mobile ECG Recording Technology to Detect Atrial Fibrillation in Low-Resource SettingsEvans et al.Dec 1, 201712(4): 285-289DownloadPDF (English)Dec 1, 201712(4): 285-289
Secondary CV Prevention in South America in a Community Setting: The PURE StudyAvezum et al.Dec 1, 201712(4): 305-313DownloadPDF (English)Dec 1, 201712(4): 305-313
Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999–2013Kotseva et al.Dec 1, 201712(4): 315-322DownloadPDF (English)Dec 1, 201712(4): 315-322
Availability, Use, and Barriers to Cardiac Rehabilitation in LMICRagupathi et al.Dec 1, 201712(4): 323-334DownloadPDF (English)Dec 1, 201712(4): 323-334
Relatives’ Presence During Cardiopulmonary ResuscitationEnriquez et al.Dec 1, 201712(4): 335-340DownloadPDF (English)Dec 1, 201712(4): 335-340
Is TAVR Ready for the Global Aging Population?Bergmann et al.Dec 1, 201712(4): 291-299DownloadPDF (English)Dec 1, 201712(4): 291-299
Evaluating Health of Emerging Economies Through the Eyes of Heart Valve Disease in the Transcatheter EraArora et al.Dec 1, 201712(4): 301-304DownloadPDF (English)Dec 1, 201712(4): 301-304
Perspectives from NHLBI Global Health Think Tank Meeting for Late Stage (T4) Translation ResearchEngelgau et al.Dec 1, 201712(4): 341-348DownloadPDF (English)Dec 1, 201712(4): 341-348
The Burden of Heart, Lung, and Blood Diseases in the United States, 1990 to 2016: Perspectives from the National Heart, Lung, and Blood InstituteColes & MensahDec 1, 201712(4): 349-358DownloadPDF (English)Dec 1, 201712(4): 349-358